Nektar Therapeutics (NKTR)

10:33 AM

Nektar Q1 Loss Wider Than Expected, Revenues Fall Y/Y, Stock Down - MSN

10:33 AM

May 12, 2025

Anticipated Clinical Trial Results and Financial Stability Justify Buy Rating for Nektar Therapeutics - TipRanks

May 12, 2025

May 12, 2025

Nektar therapeutics outlines REZOLVE-AD phase 2b data and financial position for Q2 2025 - MSN

May 12, 2025

May 12, 2025

H.C. Wainwright Reiterates Buy Rating on Nektar Therapeutics (NKTR) - StreetInsider

May 12, 2025

May 12, 2025

Dendrimers And Polymer Drugs Conjugate Market to Witness - openPR.com

May 12, 2025

May 11, 2025

Nektar Therapeutics (NASDAQ:NKTR) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st

May 11, 2025

May 11, 2025

Nektar Therapeutics First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 11, 2025

May 11, 2025

Nektar Therapeutics (NASDAQ:NKTR) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025

May 09, 2025

Nektar Therapeutics’ Earnings Call Highlights Progress and Challenges - TipRanks

May 09, 2025

May 09, 2025

BTIG maintains Buy on Nektar stock, price target at $4.00 By Investing.com - Investing.com India

May 09, 2025

May 09, 2025

Insiders Sold Nektar Therapeutics At US$1.06, Meanwhile Stock Sits Near US$0.62 - simplywall.st

May 09, 2025

May 09, 2025

NEKTAR THERAPEUTICS SEC 10-Q Report - TradingView

May 09, 2025

May 09, 2025

BTIG Reiterates Buy Rating on Nektar Therapeutics (NKTR) - StreetInsider

May 09, 2025

May 09, 2025

Nektar Therapeutics (NKTR) Q1 2025 Earnings Call Highlights: Advancements in Immunology and ... - Yahoo Finance

May 09, 2025

May 09, 2025

Nektar Therapeutics (NKTR) Q1 2025 Earnings Call Highlights: Advancements in Immunology and Financial Outlook - GuruFocus

May 09, 2025

May 09, 2025

Nektar Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025

May 09, 2025

Earnings call transcript: Nektar misses Q1 2025 forecasts amid clinical progress - Investing.com

May 09, 2025

May 09, 2025

Nektar: Q1 Earnings Snapshot - The Washington Post

May 09, 2025

May 08, 2025

Nektar Therapeutics (NKTR) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 08, 2025

May 08, 2025

Nektar (NKTR) Reports Revenue Miss and Announces Key Study Timelines | NKTR Stock News - GuruFocus

May 08, 2025

May 08, 2025

Nektar Therapeutics Q1 2025 Earnings: EPS Loss of $0.24 Misses Estimate, Revenue Falls Short at $10.5 Million - GuruFocus

May 08, 2025

May 08, 2025

Nektar Therapeutics (NKTR) Misses Q1 EPS by 8c - StreetInsider

May 08, 2025

May 08, 2025

Nektar Therapeutics Reports First Quarter 2025 Financial Results | NKTR Stock News - GuruFocus

May 08, 2025

May 08, 2025

Nektar Therapeutics Q1 Loss Increases, Misses Estimates - Nasdaq

May 08, 2025

May 08, 2025

Nektar Therapeutics Reports First Quarter 2025 Financial Results - PR Newswire

May 08, 2025

May 08, 2025

Unmet Needs in Atopic Dermatitis and the Impact of Roflumilast Cream, with Raj Chovatiya, MD, PhD - HCPLive

May 08, 2025

May 08, 2025

Urothelial Carcinoma Market on Track for Major Expansion by 2034, According to DelveInsight | Infinity, QED Therapeutics, BeiGene, Eli Lilly, Roche, UroGen, NektarTherapeutics, BMS, Incyte, Abbisko - Barchart.com

May 08, 2025

May 07, 2025

Nektar Therapeutics's Earnings: A Preview - Nasdaq

May 07, 2025

May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025

May 01, 2025

Nektar to Announce Financial Results for the First Quarter on Thursday, May 8, 2025, After Close of U.S.-Based Financial Markets - Longview News-Journal

May 01, 2025

May 01, 2025

Nektar to Announce Financial Results for the First Quarter on Th - GuruFocus

May 01, 2025

May 01, 2025

Nektar to Announce Financial Results for the First Quarter on Thursday, May 8, 2025, After Close of U.S.-Based Financial Markets | NKTR Stock News - GuruFocus

May 01, 2025

May 01, 2025

Upcoming Nektar Q1 2025 Earnings Call: CEO Howard Robin to Present Financial Results May 8 - Stock Titan

May 01, 2025

May 01, 2025

Will Nektar Therapeutics (NKTR) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance

May 01, 2025

Apr 16, 2025

Treg Cell-Based Therapies Pipeline: 51+ Innovators Shaping the Future of Immunotherapy | DelveInsight - openPR.com

Apr 16, 2025

Apr 16, 2025

Nektar upgraded at Jefferies ahead of mid-stage readout for eczema drug - MSN

Apr 16, 2025

Apr 13, 2025

Nektar Therapeutics (NKTR) Shares Surge on Jefferies Upgrade - GuruFocus

Apr 13, 2025

Apr 12, 2025

Jefferies Upgrades Nektar Therapeutics (BMV:NKTR) - Nasdaq

Apr 12, 2025

Apr 12, 2025

Nektar Therapeutics (NKTR) Gains After Jefferies Upgrade - GuruFocus

Apr 12, 2025

Apr 11, 2025

Jefferies Upgrades Nektar Therapeutics (NKTR) - MSN

Apr 11, 2025

Apr 11, 2025

Sector Update: Health Care - TradingView

Apr 11, 2025

Apr 11, 2025

Jefferies Upgrades Nektar Therapeutics (LSE:0UNL) - Nasdaq

Apr 11, 2025

Apr 11, 2025

Jefferies Upgrades Nektar Therapeutics to Buy, Doubles Price Target to $2.00 - Yahoo Finance

Apr 11, 2025

Apr 11, 2025

Nektar Therapeutics Shares Rise After Upgrade From Jefferies - marketscreener.com

Apr 11, 2025

Apr 11, 2025

Why Is Nektar (NKTR) Down 38.8% Since Last Earnings Report? - Yahoo Finance

Apr 11, 2025

Apr 11, 2025

Nektar Therapeutics stock upgraded at Jefferies (NKTR:NASDAQ) - Seeking Alpha

Apr 11, 2025

Apr 11, 2025

Assessing Nektar Therapeutics: Insights From 5 Financial Analysts - Benzinga

Apr 11, 2025

Apr 11, 2025

Jefferies Upgrades Nektar Therapeutics to Buy From Hold, Adjusts Price Target to $2 From $1 - marketscreener.com

Apr 11, 2025

Apr 11, 2025

Jefferies raises Nektar stock to buy, doubles price target By Investing.com - Investing.com India

Apr 11, 2025

Apr 11, 2025

Jefferies Upgrades Nektar Therapeutics (NKTR) to Buy - StreetInsider

Apr 11, 2025

Apr 11, 2025

Jefferies Upgrades Nektar (NKTR) with Optimistic Outlook on Phase 2b Study | NKTR Stock News - GuruFocus

Apr 11, 2025

Apr 10, 2025

IL-2 ADding contenders in eczema strategy - BioWorld MedTech

Apr 10, 2025

Apr 09, 2025

Nektar Therapeutics stock hits 52-week low at $0.44 By Investing.com - Investing.com Canada

Apr 09, 2025

Apr 09, 2025

Nektar Therapeutics stock hits 52-week low at $0.44 - Investing.com

Apr 09, 2025